Medpace
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 5.9K
- Market Cap
- -
- Introduction
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
U.S. Healthcare CRO Market Projected to Reach $29.68 Billion by 2034, Growing at 7.1% CAGR
The U.S. healthcare contract research organization market is expected to grow from $15.01 billion in 2025 to $29.68 billion by 2034, driven by increasing R&D investments and technological advancements.
Clinical Trial Outsourcing Market Set to Reach $91.2 Billion by 2034, Driven by Technology Integration and Strategic Partnerships
The global clinical trial outsourcing market is projected to grow from $43.1 billion in 2025 to $91.2 billion by 2034, representing a robust CAGR of 7.46% as pharmaceutical companies increasingly rely on CROs to streamline research processes.